18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Ryuichi Harada; Yoshimi Hayakawa; Michinori Ezura; Pradith Lerdsirisuk; Yiqing Du; Yoichi Ishikawa; Ren Iwata; Miho Shidahara; Aiko Ishiki; Akio Kikuchi; Hiroyuki Arai; Yukitsuka Kudo; Kazuhiko Yanai; Shozo Furumoto; Nobuyuki Okamura

doi:10.2967/jnumed.120.244400

Research ArticleNeurology

¹⁸F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Ryuichi Harada, Yoshimi Hayakawa, Michinori Ezura, Pradith Lerdsirisuk, Yiqing Du, Yoichi Ishikawa, Ren Iwata, Miho Shidahara, Aiko Ishiki, Akio Kikuchi, Hiroyuki Arai, Yukitsuka Kudo, Kazuhiko Yanai, Shozo Furumoto and Nobuyuki Okamura

Journal of Nuclear Medicine February 2021, 62 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.120.244400

Ryuichi Harada

1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan

2Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoshimi Hayakawa

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michinori Ezura

4Department of Neurology, Tohoku University Graduate School of Medicine. 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pradith Lerdsirisuk

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yiqing Du

1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoichi Ishikawa

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ren Iwata

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Miho Shidahara

5Department of Quantum Science and Energy Engineering, Tohoku University, Sendai, Japan; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aiko Ishiki

2Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Akio Kikuchi

4Department of Neurology, Tohoku University Graduate School of Medicine. 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hiroyuki Arai

2Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yukitsuka Kudo

2Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kazuhiko Yanai

1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shozo Furumoto

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nobuyuki Okamura

3Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

6Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 2

February 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹⁸F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Journal of Nuclear Medicine Feb 2021, 62 (2) 253-258; DOI: 10.2967/jnumed.120.244400

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹⁸F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Journal of Nuclear Medicine Feb 2021, 62 (2) 253-258; DOI: 10.2967/jnumed.120.244400

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
Relationship between reactive astrocytes, by [18F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimers disease
Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum
First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis
Imaging Neuroinflammation in Neurodegenerative Disorders
Aquaporin 4 is differentially increased and depolarized in association with tau and amyloid-beta
Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis

Google Scholar

Neurology

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans

Show more Neurology

Basic

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Keywords

MAO-B
radiotracers
PET
molecular imaging

Main menu

User menu

Search

¹⁸F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Neurology

Basic

Similar Articles

Keywords